Patient-derived organ-on-a-chip platform predicts chemotherapy response in locally advanced CRC
Skip to content
The CRC Digest
◇ RESEARCH
Patient-derived organ-on-a-chip platform predicts chemotherapy response in locally advanced CRC
From a cohort of 14 primary locally advanced CRC cases, researchers engineered 8 patient-specific organ-on-a-chip models that successfully stratified patients into distinct response groups for FOLFOX versus FOLFIRI. (Bioeng Transl Med)
This content